Potential of adjunctive Mycobacterium w(MIP) immunotherapy in reducing the duration of standard chemotherapy against tuberculosis

Autor: Chahar, Mamta, Rawat, Krishan Dutta, Reddy, P.V.J., Gupta, Umesh Dutt, Natrajan, Mohan, Chauhan, Devendra Singh, Katoch, Kiran, Prasad, Godavarthi B.K.S., Katoch, Vishwa Mohan
Zdroj: Indian Journal of Tuberculosis; October 2018, Vol. 65 Issue: 4 p335-344, 10p
Abstrakt: The need to shorten the treatment duration in tuberculosis has always been felt. Immunotherapy in combination with chemotherapy has been considered a promising approach for this purpose into tuberculosis. We studied the adjuvant immunotherapeutic activity of Mycobacterium indicus pranii(MIP or Mw) in combination with conventional chemotherapy using guinea pig of pulmonary tuberculosis infected with Mycobacterium tuberculosisH37Rv via aerosol.
Databáze: Supplemental Index